Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for the Treatment of Resectable, Refractory, or Recurrent Abdominal or Pelvic Tumors in Pediatric Patients, T.O.A.S.T. I.T. Study

Conditions:   Malignant Abdominal Neoplasm;   Malignant Pelvic Neoplasm;   Recurrent Colon Carcinoma;   Recurrent Desmoplastic Small Round Cell Tumor;   Recurrent Fallopian Tube Carcinoma;   Recurrent Gastric Carcinoma;   Recurrent Liposarcoma;   Recurrent Malignant Mesothelioma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Rectal Carcinoma;   Recurrent Rhabdomyosarcoma;   Recurrent Sarcoma;   Refractory Colon Carcinoma;   Refractory Desmoplastic Small Round Cell Tumor;   Refractory Fallopian Tube Carcinoma;   Refractory Gastric Carcinoma;   Refractory Liposarcoma;   Refractory Malignant Mesothelioma;   Refractory Ovarian Carcinoma;   Refractory Primary Peritoneal Carcinoma;   Refractory Rectal Carcinoma;   Refractory Rhabdomyosarcoma;   Refractory Sarcoma;   Resectable Liposarcoma;   Resectable Malignant Mesothelioma;   Resectable Sarcoma Interventions:   Drug: Cisplatin;   Procedure: Cytoreductive Surgery;   Drug: Doxorubicin;   Drug: Hyperthermic Intraperitoneal Chemotherapy;   Drug: Sodium Thiosulfate Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials